Effect of organism aging on the development of anti-PD-(L)1 therapy-associated adverse events
Immune checkpoint inhibitor (ICI)-mediated release of immune suppression involves the risk of (re)activating the immune responses to self-tissues, which are considered ‘side effects’ of this therapy, immune-related adverse events (irAEs). Although the incidence of certain types of irAEs appears to b...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2025-09-01
|
| Sarja: | Immunological Medicine |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/25785826.2025.2564474 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|